Asensus Surgical, Inc.
(NYSE Amex Equities : ASXC)

( )
ASXC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -2.01%540.151.0%$846.77m
ABMDABIOMED, Inc. -0.23%377.233.3%$782.17m
DHRDanaher Corp. -2.20%261.170.7%$680.05m
MDTMedtronic Plc -3.72%76.180.6%$623.48m
ISRGIntuitive Surgical, Inc. -0.94%262.640.8%$530.00m
ABTAbbott Laboratories -1.44%105.420.8%$507.99m
EWEdwards Lifesciences Corp. -0.76%75.780.4%$447.08m
BDXBecton, Dickinson & Co. -0.26%237.441.0%$445.88m
SYKStryker Corp. -2.30%227.391.3%$376.10m
DXCMDexCom, Inc. 0.51%112.571.9%$295.16m
BSXBoston Scientific Corp. -0.73%43.831.0%$262.65m
BAXBaxter International, Inc. -1.46%55.191.8%$241.09m
AAgilent Technologies, Inc. -2.96%152.311.7%$214.21m
ALGNAlign Technology, Inc. -2.51%189.786.4%$211.90m
WSTWest Pharmaceutical Services, Inc. -1.05%224.281.6%$197.87m

Company Profile

Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.